Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a poor prognosis. Beyond standard systemic therapy with multikinase inhibitors, recent studies demonstrate the potential for robust and durable responses from immune checkpoint inhibition in subsets of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Keenan, Bridget P., Fong, Lawrence, Kelley, Robin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798343/
https://www.ncbi.nlm.nih.gov/pubmed/31627733
http://dx.doi.org/10.1186/s40425-019-0749-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798343/
https://www.ncbi.nlm.nih.gov/pubmed/31627733
http://dx.doi.org/10.1186/s40425-019-0749-z

Ejemplares similares